Longhena, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 3.514
EU - Europa 2.022
AS - Asia 1.893
SA - Sud America 270
Continente sconosciuto - Info sul continente non disponibili 140
AF - Africa 49
OC - Oceania 4
Totale 7.892
Nazione #
US - Stati Uniti d'America 3.444
SG - Singapore 635
CN - Cina 599
PL - Polonia 571
IT - Italia 393
UA - Ucraina 237
BR - Brasile 226
HK - Hong Kong 185
DE - Germania 183
FI - Finlandia 153
VN - Vietnam 147
FR - Francia 122
GB - Regno Unito 105
RU - Federazione Russa 64
BD - Bangladesh 62
IN - India 59
TR - Turchia 58
IE - Irlanda 52
CA - Canada 37
CZ - Repubblica Ceca 26
SE - Svezia 25
KR - Corea 24
MX - Messico 22
ID - Indonesia 20
BE - Belgio 18
NL - Olanda 18
AR - Argentina 16
IQ - Iraq 16
JP - Giappone 16
ES - Italia 14
ZA - Sudafrica 13
IL - Israele 10
PK - Pakistan 10
AT - Austria 9
UZ - Uzbekistan 8
KE - Kenya 7
MA - Marocco 7
AZ - Azerbaigian 6
CO - Colombia 6
EC - Ecuador 6
EG - Egitto 6
JO - Giordania 6
LT - Lituania 6
VE - Venezuela 6
CH - Svizzera 5
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
JM - Giamaica 4
TN - Tunisia 4
AU - Australia 3
DZ - Algeria 3
NG - Nigeria 3
PY - Paraguay 3
UY - Uruguay 3
AM - Armenia 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
SN - Senegal 2
SY - Repubblica araba siriana 2
BN - Brunei Darussalam 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TZ - Tanzania 1
Totale 7.754
Città #
Warsaw 568
Ashburn 348
Singapore 343
Fairfield 270
San Jose 201
Hong Kong 184
Jacksonville 175
Woodbridge 161
Chandler 150
Houston 137
Beijing 135
Brescia 122
Helsinki 119
Cambridge 118
The Dalles 115
Seattle 114
Dearborn 106
Ann Arbor 96
New York 96
Wilmington 88
Princeton 86
Council Bluffs 67
Los Angeles 63
Nanjing 54
Dublin 51
Lauterbourg 50
Munich 47
Istanbul 44
Dallas 43
Milan 43
Ho Chi Minh City 39
Dong Ket 32
Shanghai 32
Columbus 30
San Francisco 30
Santa Clara 29
Moscow 26
Boardman 25
Buffalo 24
Chicago 24
Des Moines 24
Hanoi 24
Jinan 21
Redondo Beach 20
Hebei 19
São Paulo 19
Denver 18
Orem 18
Pune 18
Shenyang 18
Brno 17
Brussels 17
Jakarta 17
Changsha 16
Tokyo 16
Phoenix 15
San Diego 15
Rome 14
Tucson 14
Atlanta 13
Hangzhou 13
San Giuliano Milanese 13
Stockholm 13
Tianjin 13
Turku 13
Brooklyn 12
London 12
Lappeenranta 11
Nanchang 11
Toronto 11
Boston 10
Norwalk 10
Nuremberg 10
Paris 10
Poplar 10
Taizhou 10
Kunming 8
Lanzhou 8
Manchester 8
Montreal 8
Tashkent 8
Cattolica 7
Guangzhou 7
Jiaxing 7
Lancaster 7
Nairobi 7
Ningbo 7
Olomouc 7
Zhengzhou 7
Amman 6
Amsterdam 6
Ankara 6
Baku 6
Mumbai 6
Pavia 6
Regensburg 6
San Donà Di Piave 6
Baghdad 5
Cagliari 5
Cairo 5
Totale 5.179
Nome #
Anionic liposomes for siRNA delivery to primary neuronal cells: evaluation of Alpha synuclein knockdown efficacy 382
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 306
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 263
Alpha-Synuclein Preserves Mitochondrial Fusion and Function in Neuronal Cells 227
Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure 226
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 225
null 222
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 208
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 208
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 206
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 196
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 187
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 177
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 175
Synapsin III alterations in Parkinson's disease 167
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 165
Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases 164
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 153
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 149
Design and Synthesis of Fluorescent Methylphenidate Analogues for a FRET-Based Assay of Synapsin III Binding 149
Synapsin III Alteration in Parkinson's disease 145
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 142
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 142
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 141
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 141
ANALOGHI STRUTTURALI DEL METILFENIDATO COME AGENTI DISEASE-MODIFYING DELLA MALATTIA DI PARKINSON 140
Synapsin III Alteration in Parkinson's disease 137
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders 131
Role of dopamine D3R and acetylcholine nicotinic receptor interaction in the regulation of dopaminergic neurons function. 130
Synapsin III and Alpha-Synuclein cooperation in the onset of synaptic pathology in Parkinson’s Disease 128
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 128
A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage 124
Synapsin III knock-out reduces AAV-alpha-synuclein overexpression-related neuropathology in the nigrostriatal system 123
The good and bad of therapeutic strategies that directly target α-synuclein 123
CAVEOLIN-1 PROMOTES PROLIFERATION AND CONFERS RESISTANCE TO OXIDATIVE STRESS-INDUCED CELL DEATH IN RHABDOMYOSARCOMA CELLS 118
Parkinson's disease: from synaptic loss to connectome dysfunction 117
. Alpha-synuclein is a crucial mediator of mitochondrial fusion and functions 114
Study of alpha-synuclein fibrillation: State of the art and expectations 113
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease 108
DORSOMORPHIN, A SELECTIVE INHIBITOR OF SMAD1/5/8 PHOSPHORYLATION, IS A POTENT ENHANCER OF MYOBLAST DIFFERENTIATION 106
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease 102
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice 100
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and synaptic protein’s redistribution 100
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy? 98
Alpha-synuclein absence affected mitochondrial fusion and functions 98
G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2 86
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease 85
Validation of synapsin III as a therapeutic target for Parkinson’s disease in the AAV-mediated alpha-synuclein mouse model 84
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype 83
Acetylated α-Tubulin and α-Synuclein: Physiological Interplay and Contribution to α-Synuclein Oligomerization 82
Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates 78
Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brain 76
The Role of Rab Proteins in Parkinson’s Disease Synaptopathy 64
Experimental Ischemic Stroke-Induced Alpha-Synuclein Pathology Enhances Endothelial Inflammatory Response and Impairs Angiogenesis 45
Living in promiscuity: The multiple partners of alpha-synuclein at the synapse in physiology and pathology 5
Totale 7.892
Categoria #
all - tutte 34.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022366 0 53 23 16 6 32 13 34 19 32 52 86
2022/2023461 59 7 13 31 53 108 6 50 77 11 23 23
2023/2024541 44 11 57 43 22 100 20 26 89 13 21 95
2024/20251.104 8 19 25 135 111 86 124 61 125 71 191 148
2025/20262.505 218 277 137 343 281 259 389 99 130 215 131 26
2026/2027106 75 31 0 0 0 0 0 0 0 0 0 0
Totale 7.892